This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Douglas E. Mattox, MD; Daniel D. Von Hoff, MD; William L. McGuire, MD

Arch Otolaryngol. 1984;110(11):721-724.

Abstract
• A hydroxylapatite assay was used to assay androgen receptor levels in 23 primary laryngeal carcinomas, nine metastatic laryngeal carcinomas, and three oropharyngeal carcinomas. The median androgen receptor level in laryngeal carcinoma was 0.7 femtomoles of receptor protein per milligran of cytosol protein. Ten patients with advanced or metastatic laryngeal carcinoma and one patient with metastatic floor of mouth carcinoma were treated with the antiandrogen flutamide. There were three short-lived partial responses (1, 2, and 2.5 months) in nine patients whose tumors could be evaluated for response. Toxic reactions consisted of mild breast tenderness, and hypercalcemia in two patients with bone metastases. Androgen receptor levels did not correlate with response to flutamide. The low androgen receptor levels in laryngeal tumors may account for the relative inactivity of the antiandrogen in laryngeal cancer.

(Arch Otolaryngol 1984;110:721-724)

Author Affiliations
From the Division of Otorhinolaryngology, Department of Surgery (Dr Mattox), and the Division of Oncology, Department of Medicine (Drs Von Hoff and McGuire), University of Texas Health Science Center at San Antonio, and the Otolaryngology Section, Audie Murphy Veterans Administration Hospital, San Antonio (Dr Mattox). Dr Mattox is now with Johns Hopkins Hospital, Baltimore.

Footnotes
Accepted for publication Aug 7, 1984.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 9, 1984.

Reprint requests to Department of Otolaryngology—Head and Neck Surgery, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21205 (Dr Mattox).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Growth Effects of Tamoxifen and Estradiol on Laryngeal Carcinoma Cell Lines
Robbins et al.
Arch Otolaryngol Head Neck Surg 1994;120:1261-1266.
ABSTRACT  

Sex Steroid Receptor Distribution in the Human Larynx and Laryngeal Carcinoma
Ferguson et al.
Arch Otolaryngol Head Neck Surg 1987;113:1311-1315.
ABSTRACT  

Estrogen Receptors in Normal Salivary Gland and Salivary Gland Carcinoma
Dimery et al.
Arch Otolaryngol Head Neck Surg 1987;113:1082-1085.
ABSTRACT  

Growth Inhibition of Laryngeal UM-SCC Cell Lines by Tamoxifen: Comparison With Effects on the MCF-7 Breast Cancer Cell Line
Shapira et al.
Arch Otolaryngol Head Neck Surg 1986;112:1151-1158.
ABSTRACT